Search

Displaying results 4371 - 4380 of 6949 in total
  1. Drug

    Pentavalent Antimony

    go.drugbank.com/drugs/DB13047
    Investigational

    Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.

  2. Drug

    Dalcetrapib

    go.drugbank.com/drugs/DB12181
    Investigational

    Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.

  3. Drug

    VP-14637

    go.drugbank.com/drugs/DB12195
    Investigational

    MDT-637 has been investigated for the treatment of Drug Safety.

  4. Drug

    Tozadenant

    go.drugbank.com/drugs/DB12203
    Investigational

    Tozadenant has been investigated for the basic science of Cocaine Dependence.

  5. Drug

    N-acetylmannosamine

    go.drugbank.com/drugs/DB12536
    Investigational

    N-acetylmannosamine is under investigation for the other of GNE Myopathy.

  6. Drug

    Spiradoline

    go.drugbank.com/drugs/DB12704
    Investigational

    Spiradoline has been investigated for the basic science of Bipolar Depression.

  7. Drug

    YMI024

    go.drugbank.com/drugs/DB32602
    Experimental

    YMI024 is a drug being investigated for inflammation-driven diseases.[L56081]

  8. Drug

    Angelica sinensis root

    go.drugbank.com/drugs/DB14336
    Investigational

    Angelica sinensis root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Mixtures: GONGFUTOUYANG protein conditioner for
  9. Drug

    Arbaclofen Placarbil

    go.drugbank.com/drugs/DB08892
    Investigational

    On May 20th, 2013, XenoPort announced plans to terminate the development of Arbaclofen Placerbil for the treatment of multiple sclerosis. … It was discovered, and has been patented by XenoPort as a new chemical entity with an improved pharmacokinetic profile compared to baclofen, which allows for sustained release properties.

    Categories: GABA-B Receptor Agonists
  10. Drug

    Sulfaquinoxaline

    go.drugbank.com/drugs/DB11464
    ExperimentalVet approved

    Sulfaquinoxaline is a veterinary medicine which can be given to cattle and sheep to treat coccidiosis.It is available in Pakistan with Sanna Laboratories in combination with Amprolium and Vitamin K as potential treatment of coccidiosis.

    Mixtures: Rhobazin Plus Solution for Oral Use